A live attenuated bovine parainfluenza virus type 3 (PIV3), harboring the fusion (F) and hemagglutinin-neuraminidase (HN) genes of human PIV3, was used as a virus vector to express surface glycoproteins derived from two human pathogens, human metapneumovirus (hMPV) and respiratory syncytial virus (RSV). RSV and hMPV are both paramyxoviruses that cause respiratory disease in young children, the ...

1. Bovine TB, caused by the bacterium Mycobacterium bovis (M. bovis), is a chronic, primarily respiratory, disease that can take a variable amount of time (from a few weeks to a lifetime) to develop from infection to clinical disease and to become infectious to other animals. The transmission rate between animals is low and the epidemic only progresses slowly: on average any infected animal is ...

Bovine respiratory disease (BRD) research has provided significant understanding of the disease over the past 26 years. Modern research tools that have been used include monoclonal antibodies, genomics, polymerase chain reaction, immunohistochemistry (IHC), DNA vaccines and viral vectors coding for immunogens. Emerging/reemerging viruses and new antigenic strains of viruses and bacteria have be...

Bovine respiratory disease (BRD) is an economically important disease of cattle and continues to be an intensely studied topic. However, literature summarizing the time between pathogen exposure and clinical signs, shedding, and seroconversion is minimal. A structured literature review of the published literature was performed to determine cattle responses (time from pathogen exposure to clinic...

Chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis (CF) and interstitial lung diseases (ILD), affect many individuals worldwide. Patients with these chronic lung diseases are susceptible to respiratory lung infections and some of these viral infections can contribute to disease pathogenesis. This review highlights the associations of lung infect...

Background: To further minimize transmission risk of blood-borne viral and prion diseases, manufacturers of therapeutic animalor human-derived proteins have implemented improved in-process pathogen-removal procedures. Objectives: To evaluate removal of transmissible spongiform encephalopathy agents (prions) and viruses using Omega 100K VR membrane filtration system (Pall Filtron, Northborough, ...